Home
Public services
Dashboard
Curated content
Startups & Scaleups
New startups
Job board
Corporates
Investors
Funding rounds
Exits
Accelerators
Workspaces
Universities
More organizations
Matching tool
Investment heatmap
Themes
Reports
Companies
Cangene
Save
Cangene
Fully integrated developer and manufacturer of immune therapeutics our first drug, winrho® sdf, has been commercially.
Launch date
1984
Employees
201-500 people
Baltimore Maryland (HQ)
http://cangene.com
https://twitter.com/emergentbiosolu
https://www.linkedin.com/company/34770/
Healthcare
biotechnology
biotechnology
Overview
Similar companies
Investments (1)
Analytics
Notes
Job openings
Innovations (0)
Cangene funding
Cangene investors
Edit
Date
Investors
Amount
Round
-
Signet Healthcare Partners
N/A
-
Dec 2013
Emergent BioSolutions
N/A
Acquisition
Total Funding
-
Related Content
Recent News about Cangene
Edit
Investments by Cangene
Edit
Twinstrand Therapeutics
ACQUISITION by Cangene Jul 2009